FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3089517941> ?p ?o ?g. }

• W3089517941 endingPage "PR01" @default.
• W3089517941 startingPage "PR01" @default.
• W3089517941 abstract "Abstract Immune checkpoint inhibitors (ICI) produce durable responses in some melanoma patients, but many patients derive no clinical benefit, and the molecular underpinnings of such resistance remain elusive. Here, we leveraged single-cell RNA-seq (scRNA-seq) from 33 melanoma tumors and computational analyses to interrogate malignant cell states that promote immune evasion. We identified a resistance program expressed by malignant cells that is associated with T-cell exclusion and immune evasion. The program is expressed prior to immunotherapy, characterizes cold niches in situ, and predicts clinical responses to anti-PD-1 therapy in an independent cohort of 112 melanoma patients. CDK4/6-inhibition represses this program in individual malignant cells, induces senescence, and reduces melanoma tumor outgrowth in mouse models in vivo when given in combination with immunotherapy. Our study provides a high-resolution landscape of ICI resistant cell states, identifies clinically predictive signatures, and suggests new therapeutic strategies to overcome immunotherapy resistance. This study will be published on Nov. 1st in Cell (Jerby-Arnon et al., Cell 2018). This abstract is also being presented as Poster A25. Citation Format: Parin Shah, Michael Cuoco, Mei-Ju Su, Johannes Melms, Rachel Leeson, Abhay Kanodia, Shaolin Mei, Jia-Ren Lin, Shu Wang, Bokang Rabasha, David Liu, Alex K. Shalek, Itay Tirosh, Peter K. Sorger, Kai Wucherpfennig, Eliezer M. Van Allen, Dirk Schadendorf, Bruce E. Johnson, Asaf Rotem, Orit Rozenblatt-Rosen, Levi A. Garraway, Charles H. Yoon, Benjamin Izar, Aviv Regev, Livnat Jerby-Arnon. A cancer cell program promotes T-cell exclusion and resistance to checkpoint blockade [abstract]. In: Proceedings of the AACR Special Conference on Melanoma: From Biology to Target; 2019 Jan 15-18; Houston, TX. Philadelphia (PA): AACR; Cancer Res 2020;80(19 Suppl):Abstract nr PR01." @default.
• W3089517941 created "2020-10-08" @default.
• W3089517941 creator A5004067604 @default.
• W3089517941 creator A5005251958 @default.
• W3089517941 creator A5011894823 @default.
• W3089517941 creator A5012379493 @default.
• W3089517941 creator A5014980845 @default.
• W3089517941 creator A5015478598 @default.
• W3089517941 creator A5017860475 @default.
• W3089517941 creator A5024446608 @default.
• W3089517941 creator A5027257637 @default.
• W3089517941 creator A5030650949 @default.
• W3089517941 creator A5034365278 @default.
• W3089517941 creator A5035538664 @default.
• W3089517941 creator A5039044023 @default.
• W3089517941 creator A5043162332 @default.
• W3089517941 creator A5043685154 @default.
• W3089517941 creator A5051189984 @default.
• W3089517941 creator A5052100404 @default.
• W3089517941 creator A5053521833 @default.
• W3089517941 creator A5055048393 @default.
• W3089517941 creator A5068525042 @default.
• W3089517941 creator A5071278264 @default.
• W3089517941 creator A5071415389 @default.
• W3089517941 creator A5071470381 @default.
• W3089517941 creator A5075766401 @default.
• W3089517941 creator A5083743078 @default.
• W3089517941 date "2020-10-01" @default.
• W3089517941 modified "2023-09-27" @default.
• W3089517941 title "Abstract PR01: A cancer cell program promotes T-cell exclusion and resistance to checkpoint blockade" @default.
• W3089517941 doi "https://doi.org/10.1158/1538-7445.mel2019-pr01" @default.
• W3089517941 hasPublicationYear "2020" @default.
• W3089517941 type Work @default.
• W3089517941 sameAs 3089517941 @default.
• W3089517941 citedByCount "0" @default.
• W3089517941 crossrefType "journal-article" @default.
• W3089517941 hasAuthorship W3089517941A5004067604 @default.
• W3089517941 hasAuthorship W3089517941A5005251958 @default.
• W3089517941 hasAuthorship W3089517941A5011894823 @default.
• W3089517941 hasAuthorship W3089517941A5012379493 @default.
• W3089517941 hasAuthorship W3089517941A5014980845 @default.
• W3089517941 hasAuthorship W3089517941A5015478598 @default.
• W3089517941 hasAuthorship W3089517941A5017860475 @default.
• W3089517941 hasAuthorship W3089517941A5024446608 @default.
• W3089517941 hasAuthorship W3089517941A5027257637 @default.
• W3089517941 hasAuthorship W3089517941A5030650949 @default.
• W3089517941 hasAuthorship W3089517941A5034365278 @default.
• W3089517941 hasAuthorship W3089517941A5035538664 @default.
• W3089517941 hasAuthorship W3089517941A5039044023 @default.
• W3089517941 hasAuthorship W3089517941A5043162332 @default.
• W3089517941 hasAuthorship W3089517941A5043685154 @default.
• W3089517941 hasAuthorship W3089517941A5051189984 @default.
• W3089517941 hasAuthorship W3089517941A5052100404 @default.
• W3089517941 hasAuthorship W3089517941A5053521833 @default.
• W3089517941 hasAuthorship W3089517941A5055048393 @default.
• W3089517941 hasAuthorship W3089517941A5068525042 @default.
• W3089517941 hasAuthorship W3089517941A5071278264 @default.
• W3089517941 hasAuthorship W3089517941A5071415389 @default.
• W3089517941 hasAuthorship W3089517941A5071470381 @default.
• W3089517941 hasAuthorship W3089517941A5075766401 @default.
• W3089517941 hasAuthorship W3089517941A5083743078 @default.
• W3089517941 hasConcept C121608353 @default.
• W3089517941 hasConcept C126322002 @default.
• W3089517941 hasConcept C1491633281 @default.
• W3089517941 hasConcept C170493617 @default.
• W3089517941 hasConcept C2777658100 @default.
• W3089517941 hasConcept C2777701055 @default.
• W3089517941 hasConcept C2778468042 @default.
• W3089517941 hasConcept C2780674031 @default.
• W3089517941 hasConcept C2780851360 @default.
• W3089517941 hasConcept C502942594 @default.
• W3089517941 hasConcept C54355233 @default.
• W3089517941 hasConcept C71924100 @default.
• W3089517941 hasConcept C86803240 @default.
• W3089517941 hasConceptScore W3089517941C121608353 @default.
• W3089517941 hasConceptScore W3089517941C126322002 @default.
• W3089517941 hasConceptScore W3089517941C1491633281 @default.
• W3089517941 hasConceptScore W3089517941C170493617 @default.
• W3089517941 hasConceptScore W3089517941C2777658100 @default.
• W3089517941 hasConceptScore W3089517941C2777701055 @default.
• W3089517941 hasConceptScore W3089517941C2778468042 @default.
• W3089517941 hasConceptScore W3089517941C2780674031 @default.
• W3089517941 hasConceptScore W3089517941C2780851360 @default.
• W3089517941 hasConceptScore W3089517941C502942594 @default.
• W3089517941 hasConceptScore W3089517941C54355233 @default.
• W3089517941 hasConceptScore W3089517941C71924100 @default.
• W3089517941 hasConceptScore W3089517941C86803240 @default.
• W3089517941 hasIssue "19_Supplement" @default.
• W3089517941 hasLocation W30895179411 @default.
• W3089517941 hasOpenAccess W3089517941 @default.
• W3089517941 hasPrimaryLocation W30895179411 @default.
• W3089517941 hasRelatedWork W11740975 @default.
• W3089517941 hasRelatedWork W17404775 @default.
• W3089517941 hasRelatedWork W19818330 @default.
• W3089517941 hasRelatedWork W2151330 @default.
• W3089517941 hasRelatedWork W334662 @default.
• W3089517941 hasRelatedWork W3521414 @default.
• W3089517941 hasRelatedWork W6189649 @default.

• next